Free Trial

vTv Therapeutics (VTVT) News Today

vTv Therapeutics logo
$16.62 +1.72 (+11.55%)
As of 09:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VTVT Latest News

vTv Therapeutics initiated with a Buy at H.C. Wainwright
vTv Therapeutics reports Q4 EPS (55c) vs ($1.67) last year
vTv Therapeutics stock surges on FDA update
vTv Therapeutics CFO to Resign in March
VTv, OnKure Terminate Cellular Drug Licensing Agreement
vTv Therapeutics Faces License Agreement Termination
Get vTv Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.

VTVT Media Mentions By Week

VTVT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VTVT
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

VTVT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VTVT Articles
This Week

0

1

VTVT Articles
Average Week

Get vTv Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:VTVT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners